Final Agenda
All times are in Eastern Time (ET).
Invited speakers (25 min talk + 5 min Q&A) // Short talks (10 min talk + 5 min Q&A)
"Short Talk Abstracts" will be chosen from submissions and will be announced after the abstract deadline.
Monday, October 19, 2026
07:30–09:00 - Breakfast
07:30–14:30 - Name Badge Pick-up
10:00–10:30 - Coffee Break
10:30–12:30 - Session 1: Cellular Aspects of Sphingolipid Homeostasis
Session Chair: Marta Lipinski, University of Maryland, Baltimore
- 10:30–11:00 - Sphingolipids as orchestrators of immune cell fate in disease, Yoe-Sik Bae, Sungkyunkwan University, Seoul, Korea
- 11:00–11:30 - When sphingoid bases become neurotoxic, Stefka Spassieva, University of Kentucky
- 11:30–12:00 - Mechanisms of quality control and ferroptosis resistance in cancer, Zhipeng Li, University of Florida
- 12:00–12:30 - Lysosomal multi-omics to identify lipid dependent mechanisms contributing to brain aging, Marta M. Lipinski, University of Maryland
12:30–13:30 - Lunch & Meet-the-Experts
13:30–14:30 - Career Development Workshop Session/Short Talk Session
- 13:30–13:45 - Autophagy receptor-inspired antibody-fusion proteins for targeted intracellular degradation, Ziwen Jiang, University of Texas at Dallas
- 13:45–14:00 - Mitochondria-ER contact sites integrate cellular stress signaling into depressive-like behavior, Jin Yeong Yoo, FASEB Early Career Researcher Award, Pohang University of Science and Technology
- 14:00–14:15 - The role of glucose in the regulation of mitochondria-lysosome contact sites, Sydney Callender, Penn State College of Medicine
14:30–15:00 - Coffee Break
15:00–16:00 - Keynote Session: NPC1 Functions as a Central Hub Connecting Organelle Contacts, Lipid Trafficking and Ca²⁺ Signalling, Frances Platt, University of Oxford
Session Chair: Ozlem Goker-Alpan, Lysosomal and Rare Disorder Research and Treatment Center
16:00–18:00 - Session 2: Protein Quality Control in Health and Disease Session Chair: Moran Dvela-Levitt, Bar-Ilan University, Ramat Gan, Israel, and Mia Horowitz, Tel Aviv University, Israel
- 16:00–16:30 - Selective degradation of protein aggregates by autophagy, Fulvio Mario Reggiori, Aarhus University, Denmark
- 16:30–17:00 - Linking endoplasmic reticulum (ER) stress to endosomal-lysosomal stress in a Drosophila model of Retinitis Pigmentosa, Hyung Don Ryoo, New York University
- 17:00–17:30 - Role of local proteolysis in synaptic function and age-related neuronal degeneration, Joe Rodriguez, The Rockefeller University
- 17:30–18:00 - Quality control mechanisms in lysosomal diseases: Unfolded Protein Response and ER Overload Response, Mia Horowitz, Tel Aviv University, Israel
18:00–19:00 - Dinner
19:00–21:00 - Poster Session 1
Tuesday, October 20, 2026
07:30–09:00 - Breakfast
08:00–11:30 - Name Badge Pick-up
09:00–10:00 - Session 3: Clinical Aspects of Sphingolipid Metabolism in Diseases
Session Chair: Ozlem Goker-Alpan, Lysosomal and Rare Disorder Research and Treatment Center
- 09:00–09:30 - Sphingolipids and life on earth: therapeutic targets in human disease, Timothy Cox, University of Cambridge, Cambridge, UK
- 09:30–10:00 - Secondary glycosphingolipid accumulation and clinical implications for lysosomal storage disorders, Uma Ramaswami, Royal Free Hospital, London, UK
10:00–10:30 - Coffee Break
10:30–11:15 - Abstract Presentations
- 10:30–10:45 - Neuroimaging markers of the severity of mucopolysaccharidoses in children, Anastasia Rykunova, Russian National Centre of Surgery named after B.V. Petrovskiy
- 10:45–11:00 - Leveraging sphingosine’s polypharmacology to overcome drug resistance, Sarah Valles, University of California, Irvine
- 11:00–11:15 - Microbial sensing by ELMO1 coordinates mitochondria–lysosome crosstalk during enteric infection, Baibaswata Saha, University of Massachusetts, Lowell
11:30–13:00 - Lunch
13:00–13:30 - Poster Session 2
13:30–15:30 - Session 4: Organelle Crossings in Cell Death Pathways
Session Chair: Tito Calí, University of Padova, Italy
- 13:30–14:00 - New mechanisms for inter-organelle contact sites in health and neurodegenerative diseases, Yvette Wong, Northwestern University
- 14:00–14:30 - Expanding split-fluorescent technologies to decode the organelle contactome and beyond, Tito Cali, University of Padova
- 14:30–15:00 - Bioactive Lipid-Mediated BAX Intra-Molecular Activation Establishes A Druggable Apoptotic Checkpoint In Cancer, Jerry Edward Chipuk, Florida International University
- 15:00–15:30 - Resolving proteostatic heterogeneity to explore protein disorder and organelle homeostasis, Yuning Hong, La Trobe University, Australia
15:30–16:00 - Coffee Break
16:00–17:40 - Session 5: Systems Biology Approaches: Dynamic Imaging Techniques and Computational Modeling of an Organelle
Session Chair: Margarita Ivanova, and Daniel Desalew, Lysosomal and Rare Disorder Research and Treatment Center
- 16:00–16:30 - ER-associated control of axonal vesicle trafficking during neuronal development, Gia Voeltz, University of Colorado, Boulder
- 16:30–17:00 - Advanced biophysical tools for resolving genome spatial architecture and dynamics across scales and systems, Yael Shalev Ezra, Rice University
- 17:00–17:20 - Live-cell functional phenotyping of lysosomes using a dual-color fluorescent reporter, Siyang Ding, La Trobe University, Australia
- 17:20–17:40 - Real-time 3d holotomography reveals calciprotein particle trafficking, mitochondrial remodeling, and angiogenic impairment, Jeongwon Park, Korea Basic Science Institute
17:40 - Dinner (on your own)
Wednesday, October 21, 2026
07:30–08:30 - Breakfast
08:30–10:30 - Name Badge Pick-up
08:30–10:30 - Session 6: AI's Role in Exploring Organelle Cross-Talk
Session Chair: Behzad Najafian, University of Washington Medical Center
- 08:30–09:00 - Spatial Omics of Organelle Networks, Ahmet F. Coskun, Georgia Institute of Technology & Emory University
- 09:00–09:30 - Uncovering biological relationships through morphological profiling: The JUMP-Cell Painting dataset and tools, Alan Munoz, Purdue University
- 09:30–10:00 - Uncovering the principles coordinating systems-level organelle biogenesis with cellular growth, Shankar Mukherji, Washington University in St. Louis
10:00–10:45 - Coffee Break
10:45–12:15 - Session 7: Organelles as Drug Carriers
Session Chair: Mia Horowitz, Tel Aviv University, Israel
- 10:45–11:15 -Lysosome exocytosis as a therapeutic target in cancer progression, Duarte C. Barral, Universidade Nova de Lisboa
- 11:15–11:45 - Exosomes as therapeutic vesicles for treatment of neurological lysosomal diseases, Alexey Pshezhetsky, University of Montreal
- 11:45–12:15 - New evidence of the correlation between the dynamics of cognitive tests and the semi‑quantitative analysis data of the brain`s structure in children with MPS II receiving enzyme replacement therapy, Leyla Namazova-Baranova, Shenzhen MSU-BPI University
12:15–13:30 - Lunch
13:30–15:15 - Session 8: Maintenance of Organelle Homeostasis as a Therapeutic Strategy
Session Chair: Margarita Ivanova, and Daniel Desalew, Lysosomal and Rare Disorder Research and Treatment Center
- 13:30–14:00 - Chaperone-mediated autophagy at the crossroads of lysosomal homeostasis, aging, and liver cancer, Esperanza Arias-Perez, Albert Einstein College of Medicine
- 14:00–14:30 - Targeting protein misfolding where it matters: Identifying compartment-specific therapeutic strategies for protein misfolding diseases, Moran Dvela-Levitt, PhD, Bar-Ilan University, Ramat Gan, Israel
- 14:30–15:00 - Loss of ER-mitochondrial homeostasis drives T cell failure in cancer, Jessica E. Thaxton, University of North Carolina at Chapel Hill
- 15:00–15:15 - SLC29A3/ENT3 regulated autophagy counteracts NRTI toxicity, Rajgopal Govindarajan, The Ohio State University
15:15–15:45 - Coffee Break
15:45–17:30 - Session 9: Autophagy-Lysosomal Pathways and Mitochondrial Biology
Session Chair: Nuno Raimudo, Penn State College of Medicine
- 15:45–16:15 - The role of mitochondria in lysosome reformation, Anne Spang, University of Basel, Switzerland
- 16:15–16:45 - The guardians of mitochondrial metabolism: SoLute Carrier SLC25 family, Hoy Shen, Yale University
- 16:45–17:15 - Mitochondrial stress markers associate with phenotypic variability in Fabry disease, Lucia Lavalle, UCL Queen Square Institute of Neurology, UK
17:15–17:30 - Concluding Remarks
17:30–19:00 - Dinner
Thursday, October 22, 2026
07:30–09:00 - Breakfast
09:00 - Departures
